Piperidolate

Piperidolate
Clinical data
Trade names	Dactil
AHFS/Drugs.com	International Drug Names
ATC code	A03AA30 (WHO) ;
Identifiers
	IUPAC name 1-Ethylpiperidin-3-yl diphenylacetate;
CAS Number	82-98-4 ;
PubChem CID	4839;
DrugBank	DB13351 ;
ChemSpider	4673 ;
UNII	RJO31255V9;
KEGG	D08382 ;
ChEMBL	ChEMBL1474977 ;
CompTox Dashboard (EPA)	DTXSID7048164 ;
ECHA InfoCard	100.001.318
Chemical and physical data
Formula	C21H25NO2
Molar mass	323.436 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN1CCCC(C1)OC(=O)C(C2=CC=CC=C2)C3=CC=CC=C3;
	InChI InChI=1S/C21H25NO2/c1-2-22-15-9-14-19(16-22)24-21(23)20(17-10-5-3-6-11-17)18-12-7-4-8-13-18/h3-8,10-13,19-20H,2,9,14-16H2,1H3 ; Key:KTHVBAZBLKXIHZ-UHFFFAOYSA-N ;
	(what is this?) (verify)

Piperidolate is a pharmaceutical drug used to treat the symptoms of gastrointestinal disorders including gastric and duodenal ulcers, gastritis, enteritis, gallstones, cholecystitis, and biliary dyskinesia.^[1] It acts as an antimuscarinic agent.^[2]^[3] It was first approved in 1954 and is no longer marketed in the United States.^[1]

References

^ ^a ^b "Piperidolate". Inxight Drugs. National Center for Advancing Translational Sciences.
^ "Piperidolate". drugs.com.
^ Vardanyan R (2017). Piperidine-Based Drug Discovery. Elsevier Science. p. 130. ISBN 978-0-12-813428-3.

This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it.